Aleksander Slusarczyk

Warsaw, MZ, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications

Micro- and nanoplastics in the human genitourinary system: oncological impact - a systematic review.

Micro- and nanoplastics in the human genitourinary system: oncological impact - a systematic review.

Journal: BJU international
Published: May 29, 2026

Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancer.

Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancer.

Journal: Future oncology (London, England)
Published: April 27, 2026

Evaluating the Surrogacy of Pathological Complete Response at Radical Cystectomy in Neoadjuvant-based Muscle-invasive Bladder Cancer Trials.

Evaluating the Surrogacy of Pathological Complete Response at Radical Cystectomy in Neoadjuvant-based Muscle-invasive Bladder Cancer Trials.

Journal: European urology oncology
Published: April 21, 2026

Perioperative and survival outcomes of synchronous vs. metachronous upper tract urothelial carcinoma among bladder cancer patients treated with radical cystectomy and nephroureterectomy: Results from an International Multicenter Collaborative Study-On behalf of the Young Academic Urology (YAU) Urothelial Working Group.

Perioperative and survival outcomes of synchronous vs. metachronous upper tract urothelial carcinoma among bladder cancer patients treated with radical cystectomy and nephroureterectomy: Results from an International Multicenter Collaborative Study-On behalf of the Young Academic Urology (YAU) Urothelial Working Group.

Journal: Urologic oncology
Published: April 20, 2026

Comparative efficacy of perioperative systemic therapies for muscle-invasive bladder cancer: a network meta-analysis of randomized trials.

Comparative efficacy of perioperative systemic therapies for muscle-invasive bladder cancer: a network meta-analysis of randomized trials.

Journal: ESMO open
Published: April 13, 2026

Nephroureterectomy for upper tract urothelial carcinoma recurrence in bladder cancer patients treated with radical cystectomy: a multicentric propensity score matched analysis on predictors, practice patterns and survival outcomes.

Nephroureterectomy for upper tract urothelial carcinoma recurrence in bladder cancer patients treated with radical cystectomy: a multicentric propensity score matched analysis on predictors, practice patterns and survival outcomes.

Journal: World journal of urology
Published: April 12, 2026

Refining BCG-failure classifications in non-muscle-invasive bladder cancer.

Refining BCG-failure classifications in non-muscle-invasive bladder cancer.

Journal: BJU international
Published: March 20, 2026

Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow-up.

Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow-up.

Journal: BJU international
Published: March 13, 2026

Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups.

Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups.

Journal: BJU international
Published: March 03, 2026

The impact of age in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guérin.

The impact of age in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guérin.

Journal: Urologic oncology
Published: January 16, 2026

Bladder Tumor Location Matters: Trigone and Bladder Neck Involvement Predict Worse Oncological Outcomes in High-Grade Non-Muscle-Invasive Bladder Cancer.

Bladder Tumor Location Matters: Trigone and Bladder Neck Involvement Predict Worse Oncological Outcomes in High-Grade Non-Muscle-Invasive Bladder Cancer.

Journal: Annals of surgical oncology
Published: January 07, 2026

Survival Outcomes of BCG Only, BCG Plus EMDA-MMC or Upfront Radical Cystectomy in High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): A Multicentre, International, Collaborative Study from Tertiary Referral Institutions.

Survival Outcomes of BCG Only, BCG Plus EMDA-MMC or Upfront Radical Cystectomy in High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): A Multicentre, International, Collaborative Study from Tertiary Referral Institutions.

Journal: Cancers
Published: December 19, 2025
Showing 1-12 of 70

Last Updated: 09/26/2026